News from rxi pharmaceuticals corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Mar 28, 2016, 07:02 ET RXi Pharmaceuticals to Present at the Oligonucleotide Therapeutics and Delivery Conference

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics in dermatology and ophthalmology...


Mar 16, 2016, 07:02 ET RXi Pharmaceuticals To Webcast Fourth Quarter And Year End 2015 Financial Results On Wednesday, March 30, 2016

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics in dermatology and ophthalmology...


Jan 26, 2016, 07:02 ET RXi Pharmaceuticals to Present at the 18th Annual BIO CEO & Investor Conference

RXi Pharmaceuticals Corporation (NASDAQ: RXII) a biotechnology company focused on discovering and developing innovative therapies primarily in the...


Dec 21, 2015, 07:02 ET RXi Pharmaceuticals Announces the Initiation of a Phase 2 Trial in Dermatology with Samcyprone for Cutaneous Warts

RXi Pharmaceuticals Corporation (NASDAQ: RXII) a biotechnology company focused on discovering and developing innovative therapies primarily in the...


Dec 14, 2015, 07:02 ET RXi Pharmaceuticals to Present at the 8th Annual Biotech Showcase 2016

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapeutics primarily in...


Nov 12, 2015, 04:05 ET RXi Pharmaceuticals Reports Third Quarter 2015 Financial Results and Business Highlights

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapeutics primarily in...


Nov 05, 2015, 07:02 ET RXi Pharmaceuticals Announces the Initiation of a Phase 1/2 Trial in Ophthalmology with RXI-109 for Retinal Scarring

RXi Pharmaceuticals Corporation (NASDAQ: RXII) a biotechnology company focused on discovering and developing innovative therapies primarily in the...


Oct 29, 2015, 07:02 ET RXi Pharmaceuticals to Webcast Third Quarter 2015 Financial Results on Thursday, November 12, 2015

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapeutics primarily in...


Oct 21, 2015, 07:02 ET RXi Pharmaceuticals Announces Compound Selection for Cosmetic Product Development with its Novel Self-delivering RNAi Platform

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies primarily in the...


Oct 20, 2015, 07:02 ET RXi Pharmaceuticals Announces Remarkable and Positive Results with its Novel Self-Delivering RNAi Platform: Potent Reduction of Long Non-coding RNAs Demonstrated in Collaboration with Biogazelle

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies primarily in the...


Oct 15, 2015, 07:02 ET RXi Pharmaceuticals Announces Positive Interim Results in Phase 2a Dermatology Program with RXI-109

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company that owns a broad intellectual property portfolio including a unique...


Oct 12, 2015, 07:02 ET RXi Pharmaceuticals to Present at Premier Scientific Plastic Surgery Meeting

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies primarily in the...


Oct 07, 2015, 07:02 ET RXi Pharmaceuticals to Present at 14th Annual BIO Investor Forum

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies primarily in the...


Oct 05, 2015, 07:02 ET RXi Pharmaceuticals Bolsters Protection for its Novel Self-Delivering RNAi Platform with Notice of Allowance from USPTO

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies primarily in the...


Sep 29, 2015, 07:02 ET RXi Pharmaceuticals to Present at Dawson James Securities Growth Stock Conference

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies primarily in the...


Sep 28, 2015, 07:02 ET RXi Pharmaceuticals Granted Patent in China for Lead Clinical Candidate RXI-109

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies primarily in the...


Sep 15, 2015, 07:02 ET RXi Pharmaceuticals to Present at the 15th Annual Biotech in Europe Forum for Global Partnering and Investment Conference

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies primarily in the...


Sep 08, 2015, 07:02 ET RXi Pharmaceuticals Strengthens Intellectual Property Portfolio for Ocular Indications

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies primarily in the...


Aug 31, 2015, 07:02 ET RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies primarily in the...


Jul 29, 2015, 07:02 ET RXi Pharmaceuticals to Webcast Second Quarter 2015 Financial Results on Wednesday, August 12, 2015

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapeutics primarily in...


Jun 09, 2015, 07:02 ET RXi Pharmaceuticals Strengthens Intellectual Property Portfolio for Novel RNAi Platform

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapeutics, primarily in...


Jun 03, 2015, 07:02 ET RXi Pharmaceuticals Granted Notice of Allowance for Patent Covering Lead Compound, RXI-109, for Use in the Eye

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapeutics, primarily in...


Jun 02, 2015, 07:02 ET RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies primarily in the...


May 28, 2015, 07:00 ET RXi Pharmaceuticals Announces $10 Million Public Offering of Common Stock and Warrants

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapeutics, primarily in...


May 27, 2015, 07:02 ET RXi Pharmaceuticals Provides an Update on Series A and Series A-1 Preferred Stock

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies primarily in the...